Dr. Yeo Featured in Philadelphia Inquirer Story About Pancreatic Cancer Research Funding
Pancreatic cancer is the fourth leading cause of cancer deaths in the United States and according to advocacy group, Pancreatic Cancer Action Network, it could reach number two by 2020.
For Dr. Charles Yeo, chair of the Department of Surgery at Jefferson, and his colleagues, the fight against pancreatic cancer is not limited to inside the operating room. Working with patients ranges from boosting their morale to requests that they become advocates for pancreatic cancer research, which Dr. Yeo explains in an interview with the Philadelphia Inquirer, has long been underfunded.
Further, Dr. Yeo says: "We do have better drugs, but...they're not home-run drugs. We're better at diagnosing this, and more willing to take on challenges. It's not a death sentence anymore. We're optimists. We provide hope."
Read the full "Trying to raise the profile of pancreatic cancer, deadly yet lacking in research funding" story for more information.
Publication: Philadelphia Inquirer